Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Effects of Sotagliflozin Combined with Intensive Insulin Therapy in Young Adults with Poorly Controlled Type 1 Diabetes: The JDRF Sotagliflozin Study.
Journal: Diabetes technology & therapeutics
Published: July 10, 2020
Sotagliflozin added to optimized insulin therapy leads to HbA1c reduction without weight gain in adults with type 1 diabetes: A pooled analysis of inTandem1 and inTandem2.
Journal: Diabetes, obesity & metabolism
Published: April 15, 2020
Sotagliflozin Decreases Postprandial Glucose and Insulin Concentrations by Delaying Intestinal Glucose Absorption.
Journal: The Journal of clinical endocrinology and metabolism
Published: May 31, 2019
Dose-dependent glycometabolic effects of sotagliflozin on type 1 diabetes over 12 weeks: The inTandem4 trial.
Journal: Diabetes, obesity & metabolism
Published: January 22, 2019
Effects of Sotagliflozin Added to Insulin in Type 1 Diabetes.
Journal: The New England journal of medicine
Published: March 08, 2018
HbA1c and Hypoglycemia Reductions at 24 and 52 Weeks With Sotagliflozin in Combination With Insulin in Adults With Type 1 Diabetes: The European inTandem2 Study.
Journal: Diabetes care
Published: February 21, 2018
Sotagliflozin in Combination With Optimized Insulin Therapy in Adults With Type 1 Diabetes: The North American inTandem1 Study.
Journal: Diabetes care
Published: February 15, 2018
Effects of Sotagliflozin Added to Insulin in Patients with Type 1 Diabetes.
Journal: The New England journal of medicine
Published: September 14, 2017
Development of sotagliflozin, a dual sodium-dependent glucose transporter 1/2 inhibitor.
Journal: Diabetes & vascular disease research
Published: February 19, 2015
Sotagliflozin, a Dual SGLT1 and SGLT2 Inhibitor, as Adjunct Therapy to Insulin in Type 1 Diabetes.
Journal: Diabetes care
Published: November 26, 2014
LX4211 therapy reduces postprandial glucose levels in patients with type 2 diabetes mellitus and renal impairment despite low urinary glucose excretion.
Journal: Clinical therapeutics
Published: September 12, 2014
Last Updated: 09/26/2026